Cas:186377-56-0 (4R)-4-(ethylamino)-2-(3-hydroxypropyl)-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine-6-sulfonamide-1,1-dioxide manufacturer & supplier

We serve Chemical Name:(4R)-4-(ethylamino)-2-(3-hydroxypropyl)-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine-6-sulfonamide-1,1-dioxide CAS:186377-56-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

(4R)-4-(ethylamino)-2-(3-hydroxypropyl)-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine-6-sulfonamide-1,1-dioxide

Chemical Name:(4R)-4-(ethylamino)-2-(3-hydroxypropyl)-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine-6-sulfonamide-1,1-dioxide
CAS.NO:186377-56-0
Synonyms:O-Desmethyl Brinzolamide;BRINZOLAMIDE IMPURITY C
Molecular Formula:C11H19N3O5S3
Molecular Weight:369.48100
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:174.80000
Exact Mass:369.04900
LogP:2.62350

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like O-Desmethyl Brinzolamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,BRINZOLAMIDE IMPURITY C physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,BRINZOLAMIDE IMPURITY C Use and application,BRINZOLAMIDE IMPURITY C technical grade,usp/ep/jp grade.


Related News: According to the Food and Drug Administration and the Orphan Drug Designation program, orphan status applies to drugs and biologics defined as “those intended for the safe and effective treatment, diagnosis or prevention of rare diseases/disorders that affect fewer than 200,000 people in the US, or that affect more than 200,000 people, 2-(3-Fluorophenyl)-N-(3-phenylpropyl)-N-{[3′-({4-[3-(4-piperidinyl)propyl]-1-piperidinyl}carbonyl)[1,1′-biphenyl]-3-yl]methyl}acetamide trifluoroacetate manufacturers The Company has run a comprehensive range of specialized in vitro and in vivo tests on its patent-pending novel compounds to select the optimal psychedelic drug candidate for progressing towards human clinical trials. 1H-Pyrazolo[4,3-e][1,2,4]triazine, 1-butyl-3-methyl-5-(methylthio)- suppliers Only four out of the eight studies showed a reduction in ‘off’ time, and the effect did not increase with an increased dose of Nouryant.” 1-(2-acetoxy-2-methyl-cyclopropyl)-ethanone semicarbazone vendor & factory.